Renaissance Technologies’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

Renaissance Technologies’s Portfolio TCBP Stock Details TCBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3	Closed	-$5K	–	4256
2023 Q3	$5K	Sell	3 -19	-86%	-$31.4K	﹤0.01%	3604
2023 Q2	$39K	Buy	+22	New	+$70.6K	﹤0.01%	3659
2022 Q4	–	Sell	-1	Closed	-$41K	–	4514
2022 Q3	$41K	Buy	+1	New	+$56.4K	﹤0.01%	3803
2022 Q2	–	Hold	0	–	–	–	4166

Other funds holding TCBP

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies's TCBP Position: Q4 2023 in Review

Renaissance Technologies sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q4 2023, closing a stake of 3 shares — an estimated $5K sold.

Renaissance Technologies first reported a position in TCBP in Q3 2022 and held it in 3 quarters. The position peaked at $41K in Q3 2022. 3 funds tracked by Wall St. Rank hold TCBP as of Q4 2023.

Renaissance Technologies reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Renaissance Technologies sold 3 TC BioPharm (Holdings) plc American Depositary Shares shares in Q4 2023, an estimated $5K.
Renaissance Technologies first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q3 2022 and held it in 3 quarters.
Renaissance Technologies's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $41K in Q3 2022.
3 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.